Journal of Patient-Centered
Research and Reviews
Volume 9

Issue 3

Article 6

7-18-2022

Is Home Blood Pressure Monitoring Effective at Controlling
Hypertension in African American Patients? A Clin-IQ
Rebecca Nye
Wilhelm Lehmann
Deborah Simpson

Follow this and additional works at: https://aah.org/jpcrr
Part of the Cardiology Commons, Cardiovascular Diseases Commons, Community Health and
Preventive Medicine Commons, Family Medicine Commons, Health Information Technology Commons,
Health Services Research Commons, Investigative Techniques Commons, Medical Education Commons,
Patient Safety Commons, and the Primary Care Commons

Recommended Citation
Nye R, Lehmann W, Simpson D. Is home blood pressure monitoring effective at controlling hypertension in
African American patients? A Clin-IQ. J Patient Cent Res Rev. 2022;9:185-90. doi: 10.17294/
2330-0698.1944

Published quarterly by Midwest-based health system Advocate Aurora Health and indexed in PubMed Central, the
Journal of Patient-Centered Research and Reviews (JPCRR) is an open access, peer-reviewed medical journal
focused on disseminating scholarly works devoted to improving patient-centered care practices, health outcomes,
and the patient experience.

TOPIC SYNOPSIS

Is Home Blood Pressure Monitoring Effective at Controlling
Hypertension in African American Patients? A Clin-IQ
Rebecca Nye, MPH,1 Wilhelm Lehmann, MD, MPH,2,3 Deborah Simpson, PhD2,3,4
Training in Urban Medicine and Public Health (TRIUMPH) MD Program; University of Wisconsin School of Medicine
and Public Health, Milwaukee, WI; 2Family Medicine, Advocate Aurora Health, Milwaukee, WI; 3Department of Family
Medicine and Community Health, University of Wisconsin School of Medicine and Public Health, Madison, WI;
4
Department of Family and Community Medicine, Medical College of Wisconsin, Milwaukee, WI
1

Abstract

 frican Americans are disproportionately affected by hypertension, a modifiable contributor to
A
multiple chronic diseases and premature death. Primary care physicians play an important role
in hypertension control. Home blood pressure monitoring (HBPM) is an evidence-based method
for confirming diagnosis and monitoring hypertension over time. Some studies have found that
HBPM may lead to clinically relevant reductions in blood pressure when combined with additional
interventions, but few studies have focused specifically on African American populations.
Evidence of effectiveness could increase clinical recommendation of HBPM. This clinical inquiry
examined whether HBPM improves blood pressure control in African Americans with uncontrolled
hypertension. Reviewed studies included 4 randomized controlled trials and 2 comparative research
studies. Because these studies often were coupled with various co-interventions, ascertaining
the independent effects of HBPM was difficult. When examining reviews of HBPM without a cointervention and conducted independent of race, HBPM alone was insufficient to achieve long-term
changes in hypertension control. More research focused on African Americans, with use of control
groups, is needed to determine the true role for HBPM in controlling hypertension in this at-risk
patient population. (J Patient Cent Res Rev. 2022;9:185-190.)
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Clinical Question

Among African American patients with poorly controlled
hypertension within a primary care clinic, is home blood
pressure monitoring (HBPM) effective at reducing blood
pressure?
Brief Answer

Uncertain. A handful of studies have examined HBPM
within African American populations, but they were
coupled with various co-interventions that make it
difficult to ascertain the independent effects of HBPM.
Nearly all studies found improved systolic blood pressures
(SBP) among both their usual care and intervention
groups, without significant differences between them.
Independent of race, investigations of HBPM without
a co-intervention have concluded that HBPM alone is
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insufficient to achieve long-term changes in diagnosed
hypertension. Thus, to more completely answer this
clinical question, additional research using a randomized
controlled trial in African American patients comparing
an intervention group utilizing HBPM to a usual care
group, without additional co-interventions, is needed.
Level of Evidence for Answer: B.
Date Answer Was Determined: November 20, 2021.
Literature Search

Databases: MEDLINE, PubMed, CINAHL, and Google
Scholar.
Date Search Conducted: March 2021.
Exclusion Criteria: Non-English language, articles
published before 2000, article titles already included in
meta-analyses or systematic reviews that were analyzed
for this clinical inquiry (Clin-IQ).
Inclusion Criteria: Systematic reviews, meta-analyses,
randomized controlled/comparative trials, cohort studies,
and consensus guidelines published in the English language
within the date range of January 2000–February 2021.
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Search Terms: African American, home blood pressure
monitoring, uncontrolled hypertension, vulnerable,
underserved, social determinants of health.
Summary of the Issues

African American patients are disproportionately
affected by hypertension. Non-Hispanic Black adults
have the highest prevalence of hypertension at 57.1%,
compared to 43.6% of non-Hispanic White and 43.7%
of Hispanic adults.1 Nearly one-third of African
American young adults (ie, 18–44 years of age) have
hypertension according to a race-stratified analysis of
National Health and Nutrition Examination Survey
(NHANES) data from 2005 to 2016. The relatively
high prevalence of hypertension in African American
patients is multifactorial and may be attributed to
racism-induced stress, socioeconomic status, inadequate
therapy, medication-adherence challenges, health care
visit frequency, and genetic polymorphisms, among
other influences.2,3 African Americans have higher rates
of heart failure, cerebrovascular disease (including
ischemic stroke, transient ischemic attack, and
intracerebral hemorrhage), peripheral vascular disease,
sudden cardiac arrest, and sudden cardiac death. Despite
its associated risk profile, hypertension is modifiable
and effective treatment that helps control blood pressure
can lower risk for the aforementioned adverse events.4
Controlling hypertension is paramount to preserving
cardiovascular health and preventing disease and death.
Primary care physicians play a vital role in controlling
and mitigating the effects of chronic disease on patients.5
HBPM is an evidence-based method for confirming
hypertension diagnosis and monitoring hypertension
over time. When combined with additional interventions,
it may result in clinically relevant reductions in blood
pressure.6,7 The use of HBPM within a primary care
setting also can lead to an enhanced physician-patient
therapeutic relationship.8
According to NHANES data from 2011 to 2014,
19% of non-Hispanic Blacks utilized HBPM monthly
or more frequently and had the most frequent use
compared to other racial groups.9 Despite the high
rates of hypertension and rates of HBPM usage among
African Americans, most studies on HBPM have not
specifically targeted this at-risk population. Social
determinants of health, including health care access and
health literacy, may impact the use of HBPM among
African American patients. Understanding the role and
benefits of HBPM among African American patients
with poorly controlled hypertension may increase
recommendation of HBPM for these at-risk patients by
primary care clinicians.
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Summary of the Evidence

The literature search yielded 7 articles with 6 unique
datasets reporting on the effectiveness of HBPM
among African American patients.10-16 These included
4 randomized controlled trials and 3 comparative
research studies. While all 7 articles focused on HBPM
as an intervention to improve blood pressure control, the
presence of co-interventions, type of co-intervention, and
patient populations studied varied.10-16
In a 2011 cluster-randomized controlled trial titled
“Improving blood pressure control: results of home-based
post-acute care interventions,” Pezzin et al conducted
a 3-arm study of African American patients already
receiving home health care in New York.10 All patients
received their usual home care and were randomly
assigned to 1 of 3 intervention groups: 1) no additional
intervention; 2) a basic intervention consisting of a
blood pressure reduction education guide and a HBPM
with a log; 3) an augmented intervention consisting
of the basic intervention plus a hypertension support
nurse and health educator who provided hypertension
medication assessment, monitoring, education, and
self-management support. After 3 months, there was no
significant improvement in blood pressure with the basic
intervention. In the augmented intervention, patients
with stage 2 hypertension had significantly improved
outcomes — blood pressure control was increased by 8.7
percentage points compared to usual care (8.9% vs 17.6%;
P=0.01). Patients with stage 2 hypertension receiving
the augmented intervention also had an 8.3 mmHg
relative reduction in systolic blood pressure (P=0.01),
and the proportion with a ≥20 mmHg reduction in SBP
increased by 16.4 percentage points (P=0.01). Study
design limitations included nurse-level randomization to
a study group based on patient geographic location and
the nurse’s case load.10
In a 2016 follow-up to the Pezzin et al study,10 Feldman
and colleagues reported results from a prospective
comparative effectiveness study titled “Home-based
interventions for black patients with uncontrolled
hypertension: a cluster randomized controlled trial.”14
At 12 months, no significant differences in blood
pressure control rates (25% for usual care, 26% for basic
intervention, and 22% for augmented intervention),
mean SBP (143.8 mmHg, 146.9 mmHg, and 143.9
mmHg, respectively), medication intensification (47%,
43%, and 54%, respectively), or self-management score
(18.7, 18.7, and 17.9, respectively) were seen. Adjusted
SBP dropped more than 10 mmHg from baseline to 12
months among all study participants. The augmented
and basic interventions were not more effective than
usual care in increasing blood pressure control, lowering
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SBP, or improving medication intensification or patient
self-management. On average, SBP declined by 10.1
mmHg (from 155.5 to 145.4) across the 3 study arms
from baseline to 12 months. Because usual home care
led to significant improvements, the lack of differences
between groups created a high comparative effectiveness
threshold. This study was further limited by differential
attrition, with augmented patients more likely to decline
12-month follow-up.14
In a 2012 randomized comparison trial titled “Nurseled disease management for hypertension control in a
diverse urban community: a randomized trial,” Hebert
et al studied African American or Hispanic patients from
the Harlem neighborhood in New York City who had
uncontrolled hypertension.11 Patients were randomized
to receive a HBPM plus one in-person counseling session
and 9 months of phone follow-up with a registered nurse
or usual care, which included a pamphlet on controlling
blood pressure. During the trial a third arm was added,
the HBPM-alone group, which did not receive the
nurse counseling but did receive the pamphlet. After 9
months, a -7.0 mmHg difference in SBP was noted for
the nurse intervention group as compared to the usual
care group. For the HBPM-only group, there was a
+1.1 mmHg change as compared to usual care, thus it
was not more effective than usual care. At 18 months,
there were no statistically significant differences in SBP
among groups, which authors attributed to improved
hypertension control in the usual care group. There also
were no statistically significant improvements between
treatment groups at 9 or 18 months for diastolic blood
pressure (DBP). This study was limited by an irregular
recruitment process, substantial loss to follow-up, and
demographically dissimilar patients depending on study
enrollment time.11
In 2014, Ogedegbe et al12 examined the CAATCH
dataset17 in “Counseling African Americans to Control
Hypertension
[CAATCH]:
cluster
randomized
clinical trial main effects,” which randomized 30 lowresource community health centers in New York City
to intervention or usual care. The patient intervention
included multiple self-paced computer-based education
sessions focused on hypertension causes, complications,
and treatment, group and individual counseling sessions
on lifestyle modifications, and free automated HBPM.
Patients were encouraged to record their blood pressure
twice a day, 3 times per week, and bring their recorded
measurements to each study visit. Patients receiving
usual care were given printed hypertension education
information and vitamin and mineral supplements.
There also was a physician intervention that included
monthly case rounds and review with time for feedback
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on patients’ HBPM.17 Ultimately, there was no
significant intervention effect in comparison to usual
care on blood pressure control at 12 months.12 Subgroup
analysis revealed improved blood pressure control in
patients who received the intervention in smaller-sized
community health centers, in patients without diabetes
at 12 months, and in patients with moderate to good
health literacy status. Overall, the multicomponent
intervention was not better than usual care. The authors
suggested that their study outcomes may be secondary
to “poor patient compliance given the complexity of
adhering to multiple intervention components and
adopting more than one lifestyle change.”12 Limitations
included a 30% attrition rate and low patient adherence
to intervention components.12
In 2015, Yi and colleagues published “Self-blood pressure
monitoring in an urban, ethnically diverse population: a
randomized clinical trial utilizing the electronic health
record,” which centered on “medically underserved”
individuals from New York.13 The patient population was
62% Hispanic, 28% Black, and 10% White. Half of the
patients were randomized to usual care, and the other
half were randomized to an intervention that involved
receiving a HBPM, training on its use, and hypertension
education materials. The usual care participants received
a blood pressure monitor as an “incentive” at the end of
the 9-month follow-up. After 9 months, SBP decreased
similarly in both the intervention and control groups
(by 14.7 mmHg for intervention and by 14.1 mmHg for
control; P=0.70). Blood pressure control was reached in
38.9% of intervention and 39.1% of control participants
at 9 months. The “time-to-event experience” of reaching
blood pressure control was similar in the two groups.13
In this predominantly minority urban population, HBPM
was not shown to improve blood pressure control better
than usual care. Limitations included possible bias at the
largest study site, which was concomitantly undertaking
other blood pressure-related quality improvement efforts,
and the study’s inability to assess whether patients
understood their blood pressure readings and how
frequently they engaged in HBPM.13
A 2020 trial by Boulware et al titled “Hypertension
self-management in socially disadvantaged African
Americans: the Achieving Blood Pressure Control
Together (ACT) randomized comparative effectiveness
trial” centered on African American patients in a
community-based primary care clinic.15 All patients were
assigned to a community health worker and received
a HBPM followed by random assignment to 1 of 3
intervention groups: 1) no additional intervention; 2)
shared decision-making training related to hypertension
self-management; or 3) 9 weeks of “problem-solving
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behavioral self-management training.”15 Blood pressure
control rates improved in all patients from baseline,
where rates were noted to be 36%, 51%, and 52%
(based on Joint National Committee [JNC 7] criteria)
and 50%, 65%, and 69% (based on JNC 8 criteria) at
baseline, 4 months, and 12 months, respectively, with
no significant differences between intervention groups.
There were high rates of HBPM use among all 3 groups
(between 74% and 87%). Neither of the more elaborate
interventions had better hypertension control than those
who received only the community health worker and
HBPM intervention, though learning to engage in their
hypertension-related care may still benefit vulnerable
African American patients. Regular contact between
community health workers, patients, and providing
blood pressure monitors “may have helped overcome
important social support, logistical and material resource
barriers for socially disadvantaged individuals.”15
Limitations included lack of a control group and limited
generalizability in the setting of a single urban primary
care clinic.
Also published in 2020 was Still and colleagues’ pilot
randomized controlled trial titled “A community and
technology-based approach for hypertension self-management (COACHMAN) to improve blood pressure
control in African Americans: results from a pilot study,”
which randomly assigned African American patients to
the COACHMAN intervention or enhanced usual care.16
The COACHMAN intervention consisted of 4 components: 1) 6 weekly web-based hypertension education
modules; 2) HBPM for 3 months; 3) medication management using a smartphone application; and 4) up to
4 nurse counseling visits with members of the National
Black Nurses Association. Enhanced usual care consisted of printed hypertension management education materials, one web-based education session on HBPM, and
a blood pressure cuff with no requirement to monitor
over the 3-month period. After 3 months there were no
significant differences in terms of significant SBP reduction or blood pressure control. The only difference noted was that the COACHMAN intervention group had
increased antihypertensive medication adherence versus
the control group. The lack of difference between the
groups may have been due to increased self-monitoring
of blood pressure, as both groups received a home blood
pressure cuff. This study was limited by small sample
size, short time frame, and the provision of a HBPM for
all participants.16
When studies of HBPM plus additional supportive interventions (eg, counseling on treatment adherence, virtual
pharmacist counseling, telemonitoring with self-titration
of antihypertensive medications, telemonitoring with
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virtual nurse visits, and medication-behavioral management) were compared to usual care, a 2013 meta-analysis
found there was consistent benefit of HBPM with co-intervention at 12 months, with reduction in either SBP
(maximum decrease of 8.3 mmHg) or DBP (maximum
decrease of 4.4 mmHg).7 Also, HBPM alone was found
to be ineffective in one study focused solely on African
Americans.11 It is important to note that the impact of
HBPM use among African American patients may be no
different than that determined by reviews of the general
population. Primary care providers should encourage use
of HBPM among all patients, particularly in conjunction
with additional supportive interventions.
Limitations of Clin-IQ Analysis

There is a paucity of studies centered on African
Americans and HBPM. Most of those that exist are limited
by use of comparative effectiveness design and report no
differences between the usual care and intervention arms
(Table 110-16). Two studies found a statistically significant
difference in SBP between intervention and usual care,10,11
though in the first study this was true only among patients
with stage 2 hypertension,10 and in the second study the
significant difference noted at 9 months disappeared by
the 18-month follow-up.11 Nearly all other studies found
clinically relevant improved SBP among both their
usual care and intervention groups, without significant
difference between them. Studies typically provided all
participants with a HBPM, so there was often no true
control group. Additionally, the Hawthorne effect, which
occurs when individuals alter their behavior because they
are being observed,18 may have contributed to the lack
of statistically significant difference in SBP between the
usual care and intervention groups in many of the studies
conducted.
Conclusions

Given the findings of this Clin-IQ, it is important to
highlight the known advantages of home blood pressure
monitoring in the general population to guide primary
care physician decisions for African American patients.
Benefits of HBPM include reduction in clinical inertia,19
improved patient engagement,20 and increased medication
adherence.21 One systematic review of broader populations
with uncontrolled hypertension found that HBPM alone
can reduce systolic blood pressure by 3.9 mmHg and
diastolic blood pressure by 2.4 mmHg over a period of
6 months, though any difference at 12 months was no
longer statistically significant. General benefits aside,
more research focused on African American patients with
use of control groups is needed to determine the true role
for HBPM in reducing blood pressure in this at-higherrisk population.
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Table 1. Clinical Relevance and Intervention Effect Among Studies on Home Blood Pressure Monitoring in
African American Patients
Published study

Clinically relevant
differencea

Time frame

Intervention effect
compared to usual care

Pezzin et al (2011)h

Yes

3 months

Significant changeb

Hebert et al (2012)11
Ogedegbe et al (2014)12
Yi et al (2015)13
Feldman et al (2016)14
Boulware et al (2020)15

Yes
Yes
Yes
Yes
Yes

9 and 18 months
12 months
9 months
12 months
12 months

Significant changec
No difference
No difference
No difference
No differenced

Still et al (2020)16

No

3 months

No difference

Significant pre-post difference seen in systolic blood pressure for usual care group and intervention group, or intervention
group alone.
a

b
c

Only for stage 2 hypertension at 3 months.

Only at end of intervention (9 months); no significant difference at 18-month follow-up following study completion.

d

No usual care group; no difference between all three arms.

Patient-Friendly Recap
• Devices that record patients’ blood pressure at
home, or HBPM, help clinicians monitor the health
of those diagnosed with hypertension.
• Authors reviewed the literature to determine if the
benefits of HBPM seen when used in conjunction
with other interventions to lower high blood
pressure (adjusting medication, health counseling,
etc) also applied specifically to African Americans, a
patient population with higher rates of hypertension.
• In most reports, use of HBPM alone failed to reduce
blood pressure long term. While combining HBPM
with additional clinical support has proved modestly
effective in the general population, racially focused
studies are needed to confirm whether such
outcomes hold true for African Americans.
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